Clinical Trial Registration Policy

JGMDS is committed to promoting transparency, rigour, and reproducibility in clinical research. The journal requires that all clinical trials submitted for publication must be prospectively registered in a publicly accessible database. The publication of results of all randomized control trials will only be considered if the ICMJE recommendations (http://www.icmje.org/icmje-recommendations.pdf) are followed. A trial registration number and date must be included in the manuscript submitted for publication. Retrospective registration will not be considered. If the Trial was conducted without registration, the article will not be accepted for processing. The JGMDS reserves the right to reject any manuscript that does not comply with this clinical trial registration policy.
 The clinical trial must be registered in a publicly accessible database that is acceptable to the ICMJE. Examples of acceptable databases include ClinicalTrials.gov (https://clinicaltrials.gov/), the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (https://www.who.int/clinical-trials-registry-platform), and The Drug Regulatory Authority of Pakistan (DRAP) (http://www.dra.gov.pk/).
 Exceptions: In rare cases, the JGMDS may consider an exception to this policy if a clinical trial was not registered before the enrollment of the first participant due to factors beyond the control of the study sponsor or principal investigators, such as an unforeseen safety issue or the decision to terminate the study. In these cases, the authors must provide a written explanation of the circumstances to the editor.